Now we hear from the scientists on the front lines of CRISPR, covered in this post #2 of the Human Gene Editing Meeting. You can read Post #1 here. Jennifer Doudna starts off the big human gene editing science session on the current state of the human gene editing science and CRISPR. She gave an …
Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR Read More »
The National Academy of Sciences (NAS) summit on Human Gene Editing will begin in a few days on December 1 in Washington, D.C. This summit is in part the extension of discussions that started at a more informal meeting on CRISPR earlier this year in Napa organized by Jennifer Doudna and colleagues. The NAS meeting …
Live Blogging NAS Human Gene Editing Summit: #GeneEditSummit Read More »
I invite you, my blog readers, for the possible chance to guest blog here on ipscell.com with our audience above 10,000 a week of the who’s who of the stem cell world. What’s the topic? The positive! This invitation is to blog in 500 words or less about what you believe is the single best …
Guest blogging invite: what is top stem cell company & why? Read More »
I recently did a poll asking folks how they thought blogging would affect an academic’s career and got 50 responses. The results suggest that most respondents thought it was not particularly harmful to one’s career. 18% and 4% thought it mildly and strongly negative, respectively. Far more were enthusiastic as 52% and 6% thought it …
How does blogging affect an academic career? In poll most think it is a bit positive Read More »
I made it here in one piece to Berkeley at the Claremont Hotel driving through torrential rain to get here for the CIRM Board Meeting discussing the recent Institute of Medicine (IOM) report on CIRM. The Board is in intensive discussion as I type. Some members seem more in favor of change and others are …
Live Blogging the CIRM Board meeting on the IOM report Read More »
George Daley stem cell field SWAT analysis. He argues that the biggest threats to the stem cell field are premature and illegitimate clinical applications. He stresses need for innovation including by surgeons but cautions strongly against rushing therapies.
I’m getting some heat from some stem cell folks who think I should not have blogged about the Moriguchi iPS cell transplant case. Their argument seems to be it would have been preferable to either (A) not blog about the story at all or only minimally so fewer people would know about it or (B) …
Responding to critics of blogging the Moriguchi iPS cell story Read More »
What to start a blog? With my concise advice below, you should be ready to get started. I say, “Go for it!” I know there are quite a lot of people interested in starting to blog, but perhaps a bit uncertain or even intimidated by the idea. I think this is especially true amongst scientists. …
I’ve now been blogging about stem cells here on The Niche for nearly 2 years, but why do I keep doing it? I’m by no means the only one who blogs about stem cells, but it is just that professors still are reluctant in the stem cell field to blog. Two outstanding blogs that tied …